Literature DB >> 12591854

Relation between circulating soluble Fas ligand and subsequent ventricular remodelling following myocardial infarction.

T Soeki, Y Tamura, H Shinohara, K Sakabe, Y Onose, N Fukuda.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2003        PMID： 12591854      PMCID： PMC1767605          DOI： 10.1136/heart.89.3.339

Source DB:  PubMed          Journal:  Heart        ISSN： 1355-6037            Impact factor:   5.994


× No keyword cloud information.
  5 in total

1.  Molecular cloning and expression of the Fas ligand, a novel member of the tumor necrosis factor family.

Authors:  T Suda; T Takahashi; P Golstein; S Nagata
Journal:  Cell       Date:  1993-12-17       Impact factor: 41.582

2.  Increased plasma levels of the soluble form of Fas ligand in patients with acute myocardial infarction and unstable angina pectoris.

Authors:  Masumi Shimizu; Keisuke Fukuo; Shigekazu Nagata; Toshimitsu Suhara; Masashi Okuro; Kenshi Fujii; Yorihiko Higashino; Masaki Mogi; Yasuko Hatanaka; Toshio Ogihara
Journal:  J Am Coll Cardiol       Date:  2002-02-20       Impact factor: 24.094

3.  Clinical implications of circulating soluble Fas and Fas ligand in patients with acute myocardial infarction.

Authors:  T Ohtsuka; M Hamada; O Sasaki; M Suzuki; Y Hara; Y Shigematsu; T Ohtani; T Honda; K Hiwada
Journal:  Coron Artery Dis       Date:  1999-06       Impact factor: 1.439

4.  Programmed myocyte cell death affects the viable myocardium after infarction in rats.

Authors:  W Cheng; J Kajstura; J A Nitahara; B Li; K Reiss; Y Liu; W A Clark; S Krajewski; J C Reed; G Olivetti; P Anversa
Journal:  Exp Cell Res       Date:  1996-08-01       Impact factor: 3.905

5.  Expression of bcl-2 protein, an inhibitor of apoptosis, and Bax, an accelerator of apoptosis, in ventricular myocytes of human hearts with myocardial infarction.

Authors:  J Misao; Y Hayakawa; M Ohno; S Kato; T Fujiwara; H Fujiwara
Journal:  Circulation       Date:  1996-10-01       Impact factor: 29.690
  5 in total
  2 in total

1.  Relationship between residual viable myocardium and LV remodeling post-MI: Only part of the story.

Authors:  Robert J Gropler
Journal:  J Nucl Cardiol       Date:  2016-02-17       Impact factor: 5.952

2.  Relationship between TRAIL and Left Ventricular Ejection Fraction in Patients with ST-Elevation Myocardial Infarction Treated with Primary Percutaneous Coronary Intervention.

Authors:  Elena Teringova; Martin Kozel; Jiri Knot; Viktor Kocka; Klara Benesova; Petr Tousek
Journal:  Biomed Res Int       Date:  2018-07-09       Impact factor: 3.411
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.